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Objective: To contrast early-onset (60 years) and late-onset (60 years) depression in 
geriatric patients by evaluating differences in cognition, vascular comorbidity and sociological 
risk factors. Both patient groups were compared with normal subjects.
Materials and methods: We recruited 76 patients with depressive symptoms (37 late onset and 
39 early onset) and 17 normal controls matched by age and educational level. All subjects were 
assessed using a semistructured neuropsychiatric interview and an extensive neuropsychological 
battery. Vascular and sociological risk factors were also evaluated.
Results: We found a significant variation in performance between depressive patients and 
normal controls in most cognitive functions, especially memory (P  0.0001), semantic fluency 
(P  0.0001), verbal fluency, and digit-symbol (P  0.0001). Late-onset depression patients 
scored lower and exhibited more severe impairment in memory domains than early-onset 
depression patients (P  0.05). Cholesterol levels and marital status were significantly 
(P  0.05) different between the depressive groups. Both depressed groups (early- and late-
onset) were more inactive than controls (P  0.05; odds ratio: 6.02).
Conclusion: Geriatric depression may be a manifestation of brain degeneration, and the initial 
symptom of a dementia. It is important to consider this in the treatment of patients that exhibit 
late-onset depressive symptoms.
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Introduction
Aging is associated with brain lesions or other abnormalities that may contribute to 
depression.1–3 Among late-life depressive syndromes, late-onset depression has been 
conceptualized as a neurologic disease. This view has been supported by studies sug-
gesting that late-onset depression is more often associated with cognitive impairment 
and neurologic comorbidity than early-onset depression.4–7
Comorbid neurologic disorders are not always clinically evident at the initial 
presentation of late-onset depression. Once developed, late-onset depression may 
have a slow or poor response to antidepressant treatment.8,9 Frontostriatal dysfunc-
tion may be one of the critical brain abnormalities contributing to late-life depres-
sion. Functional neuroimaging studies support this view as they have demonstrated 
abnormal metabolism in frontal regions and the caudate nucleus during depressive 
states.10,11 The consistency of findings implicating a dysfunction of frontostriatal 
pathways in geriatric depression has led to the depression–executive dysfunction 
(DED) syndrome hypothesis. This hypothesis postulates that in a subgroup of elderly 
patients with depression, frontostriatal dysfunction caused by cerebrovascular disease Neuropsychiatric Disease and Treatment 2009:5 518
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or other aging-related conditions is the main predisposing 
factor for depression.9 It has been further hypothesized that 
DED syndrome has a distinct clinical presentation and poor 
long-term and short-term outcomes.9
Major depressive disorder is a highly prevalent disease 
in old age.1–3 Between 1% and 4% of the elderly experience 
major depression and this prevalence increases to between 
6% and 32% among older nursing home residents.4 Though 
the elderly constitute a major subgroup, depression frequently 
affects the younger population as well. In this demographic, 
initial onset typically occurs in the late twenties, but the 
first episodes are not usually seen until after the age of 
40 years.6,7
Epidemiologically, about 40% of cases of major depression 
in old age are characterized by recurrent depressive episodes, 
whereas only 30% reflect late-onset depression. In some 
cases, recurrent and late-onset depression is difficult to 
distinguish clinically.5
Late-onset depression is a heterogeneous syndrome that 
includes patients with high medical burden and neurologic 
disorders that may or may not be clinically evident upon 
initial onset.9
Several studies on late-onset depression focus on major 
depression but not on other subtypes, such as dysthymia, 
minor depression, unspecified mood disorder, mood disorder 
related to medical conditions (Alzheimer disease or other 
dementias), subsyndromal depression, etc. In a recent study 
by Rapp and colleagues comparing late onset with recurrent 
depression, patients in both groups were diagnosed with 
major depression.12
We hypothesize that late-onset depression syndrome 
(which includes different subtypes of depression) could be 
consistent with initial symptoms of a degenerative brain 
process.
The aim of this paper is to study geriatric depression 
syndrome by contrasting cognitive differences, vascular 
comorbidity, and sociological risk factors in the following 
patient groups:
1.  Late-onset depressive patients with depressive episodes 
first appearing after the age of 60 years.
2.  Early-onset depressive patients with depressive episodes 
first appearing before the age of 60 years.
3.  Normal subjects (those lacking signs and symptoms of 
depression or cognitive impairment).
Inclusion criteria:
•    Patients who present depressive symptoms that are 
due to psychiatric causes or are related with dementia 
(Clinical Dementia Rating Scale 1 [CDR]).
•    Patients aged more than 55 years and less than 
80 years.
•    Patients with Hamilton Depression Scale 9 points.
Exclusion criteria
•  Patients with history of drug or alcohol abuse.
•    Patients with neurological diseases (except dementia).
•    Patients with moderate or severe dementia (CDR 2, 
or CDR 3).
•    Patients with schizophrenia or schizoaffective disorder.
Materials and methods
We recruited 76 patients from two Buenos Aires community-
based outpatient hospitals, Hospital General Zubizarreta 
(public health system) and CEMIC University Hospital 
(private health system) that seek medical advice due to 
memory problems, all of whom exhibited depressive 
symptoms. In addition, we recruited 17 normal controls 
from the community.
Depressive patients were divided into two different 
groups: an early-onset depression group (39 patients) 
consisting of patients first exhibiting depressive episodes 
before the age of 60 years; and a late-onset depression 
group (37 patients), which included patients with depressive 
episodes starting after the age of 60 years.
All of them were assessed using a semistructured 
neuropsychiatric interview (administered by specialized 
psychiatrists and neurologists). Depressive syndromes were 
categorized into different diagnoses according to the Diagnostic 
and Statistical Manual of Mental Disorders (DSM IV)13 and 
International Codification of Diseases (ICD 10) criteria14 
using schedules for clinical assessment in neuropsychiatry 
(SCAN 2.1).15 Other psychiatric scales were utilized, including 
Hamilton Depression Scale16 to evaluate level of depression 
and Hamilton Anxiety Scale17 to determine level of anxiety.
Patients and normal controls were matched by age, 
education and overall cognitive status using the Mini-Mental 
State Examination (MMSE).18
We assessed vascular risk factors and co-morbidities such 
as high blood pressure (HBP), high cholesterol level (HCL), 
heavy smoking, cerebrovascular disease (CVD), and heart 
diseases. Additionally, we evaluated sociological risk factors 
of depression, such as marital status (married or unmarried; 
unmarried patients included in this research paper were 
individuals that live alone and have no emotional support) 
and level of activity (active or passive).
In order to investigate the different cognitive profiles, each 
patient underwent an extensive neuropsychological battery 
to evaluate the following areas of cognitive ability:Neuropsychiatric Disease and Treatment 2009:5 519
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•  Orientation: MMSE.18
•    Attention: Digit span (forward and backward);19 Trail 
making test “A”.20
•  Language: Boston Naming Test (BNT);21 vocabulary;22 
semantic fluency (SF);23 verbal intellectual quotient 
(IQ);22 verbal fluency (VF).23
•  Memory: Signoret memory battery;24 episodic memory: 
immediate logic memory (ILM), delayed logic mem-
ory (DLM); verbal serial learning (VSL), delayed 
serial memory (DSM), cued recall (CR), recognition 
(Recog). Buschke Selective Reminding Test, free recall 
(BSRT fr); Buschke Selective Reminding Test, cued recall 
(BSRT cr).25
•    Abstraction and reasoning: similarities and matrix 
reasoning.22
•  Visuospatial abilities: block design;22 clock-drawing test.26
•  Executive functions: Trail Making Test “B”;20 VF.23
•  IQ: Wechsler Abbreviated Scale of Intelligence.22
Written informed consent was obtained from each 
subject after they had been given a full explanation of the 
study. The research was performed in accordance with the 
International Conference of Harmonization Good Clinical 
Practice guidelines, the latest revision of the 1964 Helsinki 
Declaration (as amended in Seoul 2008), and the Buenos 
Aires Government Health Authorities.
Data analysis
Data was analyzed using the Statistical Package for Social 
Sciences version 1427 statistical package.
Demographic variables for both populations (patients and 
controls) as well as the results of neuropsychiatric and neuro-
psychological general global tests were expressed as means, 
standard deviation and medians. Quantitative variables were 
compared using analysis of variance (ANOVA). Scheffe, 
Games–Howell, and Dunnet tests were also performed for 
multiple comparisons.
The relationship between qualitative variables was 
compared by the chi-squared test. Predictive factors for 
depression were analyzed using the odds ratio (OR) with 
95% confidence intervals (95% CI).
Results
Demographic data
The mean age of depression onset for the early-onset 
depressive group was 44.84 (standard deviation [SD], 12.72) 
and for the late-onset depressive group was 68.29 (SD, 7.98). 
There were no significant differences in age and education 
among the three groups. There were no statistically significant 
general cognitive differences (assessed by MMSE) between 
the two depressive patient groups (late- and early-onset), yet 
there was a significant variation in general cognitive level 
(assessed by MMSE) between depressive patients and normal 
controls (P  0.05) (see Table 1).
Neuropsychiatric diagnoses
Diagnostic algorithms were obtained from SCAN 2.115 
according to DSM IV13 and ICD 10 criteria.14
Patients with early-onset depression (N = 39) were 
diagnosed as follows: major depression (N = 20, seven of 
whom had bipolar disorder), dysthymia (N = 7), unspecified 
mood disorder (N = 3), mood disorder due to a medical con-
dition (N = 6, three of whom had vascular dementia, two had 
Alzheimer dementia, and one had frontotemporal dementia).
Patients with late-onset depression (N = 37) were 
diagnosed as follows: dysthymia (N = 13), unspecified mood 
disorder (N = 11), major depression (N = 6), mood disorder 
due to a medical condition (N = 7; three of whom had vascular 
dementia and four had Alzheimer dementia).
Dementia diagnosis was made according to DSM IV,13 
NINCDS ADRDA (National Institute of Neurological and 
Communicative Diseases and Stroke/Alzheimer’s Disease 
and Related Disorders Association)28 criteria for probable 
Alzheimer disease, NINDS AIREN (National Institute of 
Neurological Disorders and Stroke/Association Internationale 
pour la Recherché et l’Enseignement en Neurosciences)29 for 
vascular dementia and Lund and Manchester30 criteria for 
frontotemporal dementia were used.
Neuropsychological assessment
Depressive patients versus normal controls
We found a wide variation in performance between depressive 
patients and normal controls in most cognitive functions: 
Table 1 Demographic data
Early-onset depression Late-onset depression Normal controls P value
Age (years) 65.4 ± 7.8 69.4 ± 7.6 65.4 ± 6.1 Ns
educational level (years) 9.8 ± 4.3 9.8 ± 4.3 12.5 ± 3.8 Ns
MMse 26.4 ± 3.5 25.8 ± 4.5 29.0 ± 1.0 0.015*
Notes: Values expressed are mean ± standard deviation. *Significant differences: P  0.05. NS: nonsignificant differences (P  0.05).
Abbreviation: MMse, Mini-Mental state examination.Neuropsychiatric Disease and Treatment 2009:5 520
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memory, attention, language, and executive functions 
(P  0.005) (see Table 2). The most significant differences 
were found in memory (P  0.0001): ILM, DLM, VSL, 
DSM (P  0.0001); SF (P  0.0001); VF; and digit-symbol 
(P  0.0001). As regards IQ, block design, performance IQ, 
and global IQ showed a significant variation (P  0.0001) 
between controls and depressive patients (see Table 2).
Late- versus early-onset depression patients
Memory tests revealed significant differences in deferred serial 
memory (P  0.05), as late-onset depression patients scored 
lower and exhibited more severe impairment than early-onset 
depression patients. Moreover, late-onset patients were poorer 
performers in all memory domains (see Table 2).
Late-onset depressive patients had the worst performance 
in memory domain while early-onset depressive patients had 
poorer functioning in executive tests (see Table 2).
Neuropsychiatric scales
Both Hamilton Depression Scale and Hamilton Anxiety Scale 
scores did not significantly differ between the two groups. 
Table 2 Neuropsychological assessment
Tests Early-onset  
depression N = 39
Late-onset  
depression N = 37
Normal controls  
N = 17
P value
Memory
immediate logic memory 5.0 ± 2.4 4.3 ± 2.5 7.9 ± 1.8 0.0001**
Delayed logic memory 4.6 ± 2.7 3.7 ± 2.7 7.5 ± 2.0 0.0001**
Verbal serial learning 7.4 ± 2.4 6.5 ± 2.4 9.7 ± 1.6 0.0001**
Delayed serial memory 5.8 ± 2.7 4.0 ± 3.1 8.4 ± 1.9 0.0001**&
cued recall 8.6 ± 3.2 7.1 ± 3.6 11.2 ± 0.9 0.0001**
Recognition 10.3 ± 2.3 9.9 ± 2.9 11.7 ± 0.4 0.035*
Buschke memory battery (free recall) 6.5 ± 1.9 5.2 ± 2.8 7.4 ± 1.1 0.005*
Buschke memory battery (cued recall) 7.0 ± 1.4 5.9 ± 2.5 7.6 ± 1.0 0.013*
Language
Boston Naming Test 43.2 ± 8.2 43.9 ± 9.3 52.9 ± 4.0 0.001*
Semantic fluency 12.4 ± 4.0 13.5 ± 5.2 20.1 ± 4.7 0.0001**
Verbal fluency 9.6 ± 4.6 11.4 ± 4.8 15.4 ± 3.4 0.0001**
Vocabulary 44.3 ± 12.6 47.5 ± 11.7 51.3 ± 19.6 Ns
Attention
Trail Making Test “A” 82.3 ± 57.6 82.0 ± 59.6 50.8 ±18.1 0.001*
Digit span (forward) 5.0 ± 1.0 5.3 ± 1.2 6.1 ± 1.0 0.002*
Digit–symbol 23.4 ± 11.5 25.6 ± 15.7 45.0 ± 10.6 0.0001**
Digit span (backward) 3.5 ± 1.0 3.5 ± 0.9 4.5 ± 1.3 0.004*
Executive functions
Trail Making Test “B” 239.3 ± 160.4 231.8 ± 148.8 115.4 ± 43.7 0.009*
Verbal fluency 9.6 ± 4.6 11.3 ± 4.8 15,4 ± 3,4 0.0001**
Visuospatial abilities
clock-drawing test 5.2 ± 2.3 5.2 ± 2.3 6.6 ± 0.6 0.045*
Block design 41.4 ± 7.5 44.8 ± 11.0 58.2 ± 11.6 0.0001**
Abstraction and logic reasoning
similarities 42.0 ± 11.0 47.4 ± 10.3 52.0 ± 8.2 0.021*
Matrix reasoning 40.0 ± 9.5 42.3 ± 13.0 55.0 ± 6.4 0.003*
Intellectual quotient
Verbal iQ 90.5 ± 14.4 95.6 ± 16.8 107.4 ± 11.6 0.014*
Performance iQ 86.4 ± 11.3 91.3 ± 15.5 110.4 ± 8.7 0.0001**
global iQ 87.5 ± 23.4 93.7 ± 14.0 110.5 ± 8.3 0.0001**
Notes: Neuropsychological battery values expressed are mean + standard deviation. *Significant differences: P  0.05 between normal and (early- and late-onset) depression 
patients. &Significant differences between early- and late-onset depression patients.
Abbreviations: IQ, intelligence quotient; NS, nonsignificant differences (P  0.05).Neuropsychiatric Disease and Treatment 2009:5 521
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Both depressive groups displayed similar levels of anxiety 
and depression (see Table 3).
Depressive patients versus normal 
controls
Vascular risk factors and comorbidity
There were nonsignificant differences between depressive 
patients and normal control groups with respect to vascular 
risk factors or comorbidities (see Table 5).
sociological risk factors for depression
Significant differences (P  0.05) were immediately 
apparent between depressive patients and normal controls 
in sociological risk factors, such as level of activity. The 
OR for developing depression was 6.02 in inactive patients 
(see Table 4).
Late- versus early-onset depression 
patients
Vascular risk factors and comorbidity
Significant differences were observed in cholesterol 
levels (P  0.05) between both depressive subtypes 
(early versus late); high cholesterol levels were especially 
prevalent in early-onset depressive patients (see Table 5).
sociological risk factors of depression
Significant differences (P  0.05) were shown in marital 
status between depressive groups, with a tendency towards 
lack of a stable emotional environment in early-onset patients 
(OR, 4.6). However, activity levels were similar in both 
groups (see Table 5).
As demented patients were present in both depression 
groups and we thought this might have some kind of impli-
cation on neuropsychological results, we excluded these 
patients (six early-onset depression patients with mood 
disorder due to a medical condition and seven late-onset 
depression patients with mood disorder due a to medical 
condition) and analyzed the new results.
Neuropsychological assessment
Depressive patients (without demented patients) 
versus normal controls
We found remarkable differences in performance between 
depressive patients and normal controls in most cognitive 
functions, particularly in memory, attention, language, and 
executive functions (P  0.005) (see Table 6). However, 
performance in visuospatial function (clock-drawing test) did 
not differ significantly. In spite of the fact that we removed 
demented patients from both groups, we observed a similar 
neuropsychological pattern to the one described above.
Early-onset depression: this group of depressive patients 
exhibited greater impairment in executive functions (VF) 
and attention (digit span forward and backward) than normal 
controls (see Table 6).
In late-onset depression patients, the memory domain 
was remarkably affected in comparison to normal controls 
(P  0.05) (see Table 6).
This contributes to support even more the fact that a dif-
ferent neuropsychological profile exists between late- and 
early-onset depression patients.
Discussion
This study revealed that depressive patients underwent 
a general cognitive impairment, evidenced by differ-
ences in neuropsychological test performance relative to 
normal controls; performance differences were especially 
pronounced in memory domain and executive func-
tions. Clinical studies have shown that diseases related 
Table 3 Neuropsychiatric assessment
Neuropsychiatric 
assesment
Early-onset 
depression 
N = 39
Late-onset 
depression 
N = 37
P value
hamilton Anxiety scale 17.5 ± 8.0 14.1 ± 5.7 Ns
hamilton Depression scale 17.1.4 ± 7.1 15.5 ± 4.4 Ns
Note:   Values expressed are mean + standard deviation.
Abbreviation: NS, nonsignificant differences (P  0.05).
Table 4 Risk factors. Depressive patients versus normal controls
Risk factors Depressives Controls P value* OR (CI)
Level of activity 
(Passive/Active)
(43/23) (4/13) 0.005 6.07 (2–20)
Marital status 
(Married/Lonely)
(25/42) (3/12) Ns
high blood 
pressure level 
(Yes, No)
(33/42) (4/13) Ns
Diabetes (Yes, No) (7/68) (0/17) Ns
high cholesterol 
level (Yes, No)
(36/39) (4/13) Ns
heart disease 
(Yes, No)
(24/51) (1/16) Ns
cerebrovascular 
disease (Yes, No)
(9/66) (1/16) Ns
heavy smoking 
(Yes, No)
(23/52) (7/10) Ns
Note: *chi-squared test.
Abbreviations: CI, confidence interval; OR, odds ratio.Neuropsychiatric Disease and Treatment 2009:5 522
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to frontostriatal dysfunction predispose patients to 
depression and lead to executive function impairment in 
problem solving, sequencing, planning, organizing, and 
abstracting.6,31 Moreover, geriatric depression, even in the 
absence of a diagnosable neurological disease, is often 
accompanied by executive dysfunction.7
However, the most important trend that emerged in this 
study was that late-onset depression patients showed greater 
memory impairment than the early-onset group. In addition, 
early-onset patients had executive dysfunction. Moreover, 
late-onset depression patients showed greater impairment 
than early-onset depression patients. This demonstrates 
a different neuropsychological profile between these two 
groups of depressive patients.
Late-onset depression patients had greater impairment in 
episodic memory tests while early-onset depression patients 
had predominance of executive dysfunction. Episodic 
memory is subserved by the hippocampus while executive 
functions are related to frontostriatal and subcortical 
pathways. The first symptom observed in Alzheimer disease 
is impairment in episodic memory which is related to 
hippocampal atrophy, while in vascular cognitive impairment 
is evidenced through executive dysfunction.
What seems to differentiate this investigation from others 
is that in many studies late-onset depression is related to 
executive dysfunction probably due to cerebrovascular 
disease. However, in this research executive functioning 
is more related to early-onset depression than to late-onset 
depression.
Moreover, in this investigation we included different 
subtypes of depressive syndromes and found that the 
early-onset depression group was especially prone to major 
depression, while the late-onset group tended to exhibit 
unspecified mood disorder and dysthymia.
According to the previous findings, we could speculate 
that late-onset depression seems to be more related to a 
degenerative process, as episodic memory is the predominant 
affected. If this is so, some subtypes of late-onset depression, 
that maybe do not conform DSM IV criteria for major depres-
sion such as dysthymia or unspecified mood disorder, could 
be a clinical prodromal of Alzheimer disease. It is currently 
not clear whether prior depression is a true etiologic risk 
factor for dementia or rather represents a prodromal clinical 
manifestation of dementia neuropathology.32
The loss of hippocampal volume and memory function 
observed in some elders with late-life depression suggests 
the possibility that depression may be a predispositional 
risk factor for Alzheimer disease in particular. Indeed, lower 
hippocampal volumes independently predict subsequent 
Alzheimer disease in groups of mild cognitively impaired 
patients and cognitively normal elderly patients.33 Like-
wise, deficits in verbal learning and memory, similar to 
those described in euthymic patients with history of major 
depression, also predict Alzheimer disease.34
Some structural magnetic resonance imaging (MRI) studies 
find that hippocampal atrophy is more strongly associated with 
late-onset than early-onset depression, suggesting that early 
Alzheimer disease-related pathophysiology could generate 
both hippocampal atrophy and depressive symptoms in some 
elderly persons.35,36 In addition, one of these studies failed to 
find a significant correlation between hippocampal volume 
and cortisol level among elders with depression. Furthermore, 
the late-life depression subjects showed persistent memory 
and cognitive impairment at six-month follow-up despite 
effective treatment of mood symptoms and normalization 
of cortisol levels.36 All of these data are consistent with the 
idea that Alzheimer disease pathology is a major cause of 
hippocampal atrophy in some (but not all) individuals with 
late-life depression, and their depressive symptoms may 
represent prodromal Alzheimer disease.32
Butters and colleagues propose that depression alters 
an individual’s risk of cognitive dysfunction, shortening 
Table 5 Risk factors in early-onset depression versus late-onset depression
Risk factors Early-onset Late-onset P value* OR (CI)
Level of activity (Passive/Active) (22/13) (21/10) Ns
Marital status (Married/Lonely) (19/17) (25/6) 0.01 4.6 (1.5–14)
high blood pressure level (Yes, No) (14/24) (19/18) Ns
Diabetes (Yes, No) (6/32) (1/36) Ns
high cholesterol level (Yes, No) (23/15) (13/24) 0.028 Ns
heart disease (Yes, No) (8/30) (16/21) Ns
cerebrovascular disease (Yes, No) (4/34) (5/32) Ns
Tobacco abuse (Yes, No) (12/26) (11/26) Ns
Abbreviations: CI, confidence interval; NS, nonsignificant; OR, odds ratio.Neuropsychiatric Disease and Treatment 2009:5 523
geriatric depression in a memory research center Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
Table 6 Neuropsychological assessment
Tests Early-onset 
depression N = 32
Late-onset 
depression N = 30
Normal controls  
N = 17
P value
Memory
immediate logic memory 5.5 ± 2.3 4.9 ± 2.2 7.9 ± 1.8 0.0001*
Delayed logic memory 5.1 ± 2.6 4.3 ± 2.5 7.5 ± 2.0 0.0001*
Verbal serial learning 7.5 ± 2.3 7.0 ± 2.2 9.7 ± 1.6 0.0001*
Delayed serial memory 6.0 ± 2.5 4.6 ± 3.0 8.4 ± 1.9 0.0001*
cued recall 8.8 ± 3.2 7.7 ± 3.3 11.2 ± 0.9 0.0001*
Recognition 10.3 ± 2.4 10.6 ± 1.8 11.7 ± 0.4 0.03*
Buschke Memory battery (immediate memory) 6.8 ± 1.8 5.9 ± 2.4 7.4 ± 1.1 0.036$
Buschke Memory battery (cued memory) 7.3 ± 1.1 6.5 ± 1.9 7.6 ± 1.0 Ns
Language
Boston Naming Test 44.5 ± 7.7 45.7 ± 7.5 52.9 ± 4.0 0.001*
semantic Fluency 13.1 ± 4.0 14.6 ± 4.9 20.1 ± 4.7 0.0001*
Verbal Fluency 10.4 ± 4.4 12.5 ± 4.5 15.4 ± 3.4 0.001#
Vocabulary 46.7 ± 11.9 49.5 ± 10.8 51.3 ± 19.6 Ns
Attention
Trail Making Test “A” 64.4 ± 29.3 74.3 ± 50.6 50.8 ±18.1 Ns
Digit span (forward) 5.1 ± 1.0 5.3 ± 1.3 6.1 ± 1.0 0.010#
Digit span (backward) 3.5 ± 1.0 3.7 ± 0.8 4.5 ± 1.3 0.032#
Digit–symbol 27.0 ± 9.9 28.6 ± 15.3 45.0 ± 10.6 0.0001*
Executive functions
Trail Making Test “B” 209.2 ± 144.5 220.7 ± 142 115.4 ± 43.7 0.023*
Verbal fluency 10.4 ± 4.4 12.57 ± 4.6 15,4 ± 3,4 0.001#
Visuospatial abilities
clock-drawing test 5.56 ± 2.1 5.7 ± 1.7 6.6 ± 0.6 Ns
Block design 42.7 ± 7.5 46.3 ± 11.3 58.2 ± 11.6 0.0001*
Abstraction and logic reasoning
similarities 44.0 ± 10.9 48.1 ± 10.6 52.0 ± 8.2 Ns
Matrix reasoning 40.5 ± 9.8 43.2 ± 14.1 55.0 ± 6.4 0.005*
Intellectual quotient
Verbal iQ 93.6 ± 13.6 98.4 ± 15.2 107.4 ± 11.6 0.03#
Performance iQ 87.8 ± 11.5 93.4 ± 16.2 110.4 ± 8.7 0.0001*
global iQ 89.9 ± 11.8 96.1 ± 13.9 110.5 ± 8.3 0.0001*
Note:   Values expressed are mean + standard deviation. *Significant differences: P  0.05 between normal and (early- and late-onset) depression patients. #Significant differences 
between early-onset depression patients and normal controls. $Significant differences between late-onset depression patients and normal controls.
Abbreviations: NS, nonsignificant differences (P  0.05); iQ, intelligence quotient.
the latent period between the development of Alzheimer 
disease neuropathology and the onset of clinical dementia, 
thus increasing the incidence and prevalence of Alzheimer 
disease among older adults with depression.
Many individuals with late-onset depression may be in 
the prodromal stage of Alzheimer disease, their hippocampus 
having already sustained substantial neuronal injury due to 
cumulative Alzheimer disease neuropathology.32
Late-onset depression and cognitive impairment usually 
go hand-in-hand, a trend that suggests a close association 
between the two.37,38 It is not known, however, which is 
causal.38,40Neuropsychiatric Disease and Treatment 2009:5 524
Dillon et al Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
Clinical practice and research evidence suggest that 
depression is a risk factor for cognitive decline in old age. It is 
quite difficult to affirm this association, because these studies 
are limited by the assumption that cognitive impairment is 
a result of depression itself, and fail to explore other causal 
relationships.41–43 This association could not be confirmed by 
other investigations.44–47
Depression may very well be an early sign of, rather 
than an independent risk factor for, cognitive impairment, 
and as such, the temporal relationship between the two in 
old age remains unclear. In fact, the few studies that have 
undertaken both causal relationships have quite convinc-
ingly shown that depression in old age is a concomitant 
phenomenon of an already existing cognitive impairment 
rather than an independent risk factor.
Another important data observed in this study was that 
both groups scored similarly in Hamilton Depression Scale 
and Hamilton Anxiety Scale, which shows a degree of 
homogeneity in relation to the depressive symptoms.
No variable occurrences were observed in vascular risk 
factors and comorbidity between depressives and normal 
controls. However, differences were evident between 
depressive groups as early-onset depressives exhibited high 
cholesterol levels.
As regards to sociological variables, inactive patients 
were much more likely to develop depression than those 
who were engaged in regular activity (OR, 6.02). Marital 
status played an important role when looking at depression 
groups. Late-onset depression patients were more frequently 
married while early-onset depressives were more often 
unmarried (which in our investigation was related to a lack 
of emotional support).
Prospective studies reveal a higher incidence of depres-
sion in women than in men.48 Other potential risk factors 
include marital status,49–51 concomitant diseases,49 low 
education, functional disability (which can correlate with 
inactivity),52 and alcohol abuse. Social isolation, physical 
inactivity, and lack of leisure cognitive activity may result 
in lowered reserve and therefore confer additional risk for 
exhibiting clinical symptoms of dementia.32
Conclusion
According to the results of the present study, depressive 
patients (both early- and late-onset) had significantly 
lower performances, in comparison to normal controls, in 
all neuropsychological tests. Furthermore, the late-onset 
depression group had more cognitive impairment than the 
early-onset depression group, in spite of the fact that in 
both groups’ patients with dementia were present in similar 
number. These results might support the theory that cognitive 
decline causes late-onset depression, which may be correlated 
with a degenerative biological brain change.
Unspecified mood disorder was significantly prevalent 
in the late-onset depressive group. According to DSM IV13 
and ICD 1014 classifications, this diagnosis is made when 
mood disorders do not meet any criteria for depressive 
disorders, so it should be considered when evaluating 
late-onset depression.
Inactivity and lack of social interaction are examples of 
severe life stress events that may lead to increased depres-
sion in individuals.
Artero and Ritchie53 examined the evidence for a separate 
nosological entity of late-onset depressive episodes. Their 
studies showed that late-onset depression is likely due to 
various underlying causes and should not be classified as an 
independent disease entity. van den Berg and colleagues54 
divided late-onset depression patients into two subgroups 
with distinct etiological pathways: one through the experi-
ence of severe life stress, and the other through degenerative 
biological brain changes.
The literature on depression and dementia has always been 
somewhat contradictory. There are three main hypotheses55 
that attempt to explain the association: (1) depression may be 
a psychological reaction to eroding cognitive capacities early 
in the course of dementia; (2) a common underlying central 
nervous system disorder may be the cause of depression, 
as well as cognitive decline in elderly persons; it has been 
shown that elderly depressed people have more frequent and 
more severe white matter and other subcortical abnormalities 
on brain magnetic resonance imaging; (3) depression may 
be associated with high levels of cortisol, which can lead 
to neuronal death and deregulation of the hypothalamic-
pituitary adrenal axis resulting in hippocampal atrophy and 
cognitive decline. Several studies have found links between 
late-onset depression and Alzheimer’s disease.56–59
Depression is a mental disease that affects not only the 
psychological well-being of a patient (by causing mood dis-
orders), but also his/her neuropsychological profile (through 
cognitive impairment). Geriatric depression may be a sign of 
brain degeneration and the initial symptom of a dementing 
disorder. It is important to consider this in patients whose 
depressive symptoms begin after the age of 60 years.
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